U.S. Ruling Class Received $400 Million In Royalties From Moderna

The United States government has released the licensing agreement it hammered out with vaccine manufacturer Moderna and it’s highly concerning. The ruling class received $400 million in royalties for helping to “sell” the COVID-19 experimental gene therapy shots to the public.

COVID-19 mRNA Shots Are Legally Not Vaccines

As of right now, the rulers have refused to confirm any payment details. According to a report by The Epoch Times, Moderna agreed to pay the U.S. National Institutes of Health (NIH) to license spike protein technology. This is confirmed in the contract that the company and the U.S. ruling class agreed to with regard to its COVID-19 vaccine.

The Epoch Times was able to obtain this contract through the Freedom of Information Act.

Moderna resisted for years acknowledging the work by government researchers on the spike protein but relented in late 2021 and announced the contract during an earnings call on Feb. 23. Moderna said it provided a “catch-up payment” of $400 million to the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the NIH, under the agreement.

If you ever thought this was about health, you’ve been wrong the whole time. Follow the money. This was a wealth transfer from the beginning:

The newly disclosed contract says that Moderna would pay the NIH a “non-creditable, nonrefundable royalty in the amount of Four Hundred Million dollars.”

Portions that would confirm Moderna’s statement that the company would pay “low single-digit royalties” on future sales of its COVID-19 vaccines are redacted.

The contract, running 34 pages, has key sections redacted as to future royalties.

One section, for instance, says, “The licensee agrees to pay to the NIAID earned royalties on net sales … as follows.” But the rest of the section is redacted. –The Epoch Times

They redacted the royalties, even though there have been press releases about the royalties,” James Love, director of the nonprofit Knowledge Ecology International, told The Epoch Times via email. “It’s common but [expletive] to redact royalties on a negotiated license on a government patent.”

The contract was signed on Dec. 14, 2022, by Michael Mowatt, director of the Technology Transfer and Intellectual Property Office at the National Institute of Allergy and Infectious Diseases, and Shannon Klinger, chief legal officer at Moderna.

The payments would include a royalty within 60 days after government officials provided a “reasonable detailed written statement and request” for an amount “equivalent to a pro-rata share of the unreimbursed patent expenses previously paid by the NIAID.” –The Epoch Times

The NIH said that the reason for the redactions is an exemption to the act that enables agencies to withhold “trade secrets and commercial or financial information obtained from a person and privileged or confidential.”

Moderna has made nearly $37 billion from its COVID-19 vaccines during the scamdemic. It has forecast $5 billion in revenue from the vaccines in 2023. Moderna and Pfizer both received enormous government contracts for their vaccines, which helped in their development and manufacturing.

- Advertisement -

Links to check out

Latest Articles